Fig. 5. Expression of fusion proteins between teneurin-2 and the recombinant transcription factor BDAD. Western blot analysis (A) and immunofluorescence staining (B) of BDAD and three different BDAD-teneurin-2 fusion constructs in HT1080 cells using anti-Gal4 antibodies. (A) Transient transfection with constructs pBD-NFB expressing BDAD, BDAD-I, BDAD-ITE and BDAD-ITEY in the presence (+) or absence (-) of ALLN, as indicated above the lanes. (B) Immunofluorescence analysis of permeabilized cells transfected with BDAD-I and of non-permeabilized cells with either BDAD-ITE or BDAD-ITEY using anti-Gal4 to detect BDAD-I and anti-teneurin-2 for BDAD-ITE and BDAD-ITEY. Staining of BDAD-ITE- or BDAD-ITEY-transfected cells with anti-Gal4 after permeabilization resulted in addition to the cell surface staining in ER and Golgi staining, but no nuclear staining could be detected (data not shown). BDAD-I did not accumulate in PML bodies but was diffusely distributed throughout the nucleus and was strongly protected from degradation in the presence of the proteasome inhibitor ALLN. Bar, 20 µm.

Return to article